Skip to main content
. 2020 Apr 3;19(6):4151–4160. doi: 10.3892/ol.2020.11509

Table III.

Association between mefenamic acid treatment and therapeutic effect.

Parameters of therapeutic effect Mefenamic acid group (%) Placebo group (%) RR (95% CI) NNT P-value
Response 40   0 0.63 (0.38–1.05) 3.00 0.081
Progression   0 70 0.12 (0.01–0.85) 1.71 0.033

Response is defined ≥50% decrease in PSA levels and progression is defined as ≥25% increase in PSA levels. CI, confidence interval; NNT, number needed to treat; PSA, prostate specific antigen; RR, relative risk.